couter

Oct 15, 2026 — Strategic Refinancing / Dilutive Equity Raise
Chart by TradingView

The schedule

  • Thu15Oct

    Given extreme leverage (Net Debt/EBITDA 22.7x) and microscopic cash reserves, a dilutive restructuring or toxic debt issuance is highly anticipated.

  • Mon16Nov

    Q3 2026 earnings announcement, acting as a critical viability check for the company's remaining IT services and potential digital asset ventures.

  • Mon30Nov
  • Mon15Feb

    Potential regulatory review of CCTL's listing status on OTC markets, assessing minimum financial and reporting compliance.

  • Mon1Mar
  • Mon31May
  • Mon30Aug

Past

  • Mon31Aug

    CCTL's Q2 2026 earnings release, expected around August 31, where the market will assess if the $15K cash position can sustain operations.